AI-assisted international press reviewPress review
Mars and Unreasonable Group Launch Thirteen New Companies for Sustainable Food System
As part of their Unreasonable Foodâ„¢ collaboration, Mars and Unreasonable Group welcome thirteen innovative new companies aimed at transforming the global food system. These initiatives focus on sustainability and tackle crucial issues such as gut health, ingredient innovation, and food security, building on the successes of previous cohorts that have already generated millions in revenue and contributed to reducing COâ‚‚ emissions.
Source: Mars Incorporated, published under the title "Mars and Unreasonable Group welcome thirteen new ventures to..." - 15 September 2026
Read more
AI in Oncology: Untapped Potential According to Johnson & Johnson
A survey by Johnson & Johnson reveals that while most community oncologists believe in AI to enhance care, its usage remains limited. Barriers include a lack of training and infrastructure, necessitating investments to turn this technology into real benefits for patients.
Source: J&j - 15 September 2026
Read more
Abbott Reaches $385 Million Settlement Over Infant Formula Recall Claims
Abbott has agreed to pay $385 million to settle claims without admitting fault, following tests that showed no contamination by Cronobacter sakazakii in its unopened products. The CDC also stated that there was no link between the Sturgis plant and reported infection cases, emphasizing that contamination often occurs at home.
Source: Abbott, published under the title "Abbott Reaches Agreement With Department Of Justice To Resol..." - 15 September 2026
Read moreRYBREVANT: A Major Breakthrough in Lung Cancer Treatment
The results of the PAPILLON study reveal that the combined treatment of RYBREVANT and chemotherapy offers a median overall survival of 34.3 months for patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations, establishing a new standard in this historically challenging patient population.
Source: J&j - 14 September 2026
Read more
ScottishPower Enhances Wind Farm Safety with New Contract
ScottishPower Renewables has signed a contract with Vroon Offshore Services to provide emergency and rescue services during the construction of the East Anglia TWO and THREE offshore wind farms, a project that will generate enough renewable electricity to power over two million homes and support thousands of jobs.
Source: Iberdrola, published under the title "ScottishPower reinforces security at its East Anglia wind fa..." - 14 September 2026
Read more
UGL Secures Contract for Sybella Solar and Energy Storage Project
UGL, a subsidiary of the CIMIC Group, has secured a contract for the construction of a 72 MW solar farm and a 52 MW energy storage system in Mount Isa, Queensland. This project aims to strengthen the renewable energy infrastructure in the region, contributing to Australia's energy transition and Queensland's energy security. Construction is expected to commence in late 2026 and conclude by mid-2028.
Source: Hochtief, published under the title "CIMIC'S UGL awarded contract for APA's Sybella Solar and Bat..." - 14 September 2026
Read more
Tagrisso: A Major Breakthrough in Treating EGFR-Mutated Lung Cancer
Results from the Phase III ADAURA trial reveal that Tagrisso provides a durable eight-year survival benefit for patients with EGFR-mutated non-small cell lung cancer, reinforcing its status as a standard treatment in this indication. Nearly 80% of treated patients are alive after eight years, highlighting the importance of early mutation screening to optimize clinical outcomes.
Source: Astrazeneca, published under the title "Tagrisso demonstrated unprecedented eight-year landmark surv..." - 14 September 2026
Read more
ISPE Conference in Singapore: Innovations in Life Sciences Highlighted
The ISPE conference in Singapore showcased advancements in the life sciences sector, while CIMIC Group announced significant contracts for renewable energy and infrastructure projects. These initiatives emphasize the importance of innovation and sustainability in the construction and engineering sectors, with a particular focus on training future engineers and ensuring the safety of ongoing projects.
Source: Cimic, published under the title "That’s a wrap on a fantastic few days at the ISPE Singapore ..." - 14 September 2026
Read moreUGL Wins Contract for Sybella Solar Farm in Mount Isa
UGL, a subsidiary of the CIMIC Group, has been selected by APA Group to design and construct the Sybella solar farm and a battery energy storage system in Mount Isa, Queensland. This 72 MW solar production and 52 MW storage project aims to enhance the renewable energy infrastructure in the region, contributing to Australia's energy transition. Construction is set to begin in late 2026, with completion expected by mid-2028.
Source: Cimic - 14 September 2026
Read more
Sumitomo Chemical to Participate in SEMICON India 2026
Sumitomo Chemical will participate in SEMICON India 2026, a major international event for the semiconductor industry, to be held in New Delhi. The company will showcase its innovative solutions for semiconductor manufacturing, highlighting its commitment to the development of this strategic industry in India and globally.
Source: Sumitomo Chemical, published under the title "Sumitomo Chemical to Attend SEMICON India 2026" - 14 September 2026
Read moreEnhertu: Promising Advances in HER2-Mutant Lung Cancer Treatment
Results from the DESTINY-Lung04 trial reveal that Enhertu significantly improves progression-free survival in patients with HER2-mutant non-small cell lung cancer, offering a new therapeutic option against standard treatments.
Source: Astrazeneca, published under the title "Enhertu demonstrated a median progression-free survival of 1..." - 14 September 2026
Read more
GSK Unveils Promising Data for Jideytro in Lung Cancer Treatment
GSK has presented encouraging results for Jideytro (zidesamtinib) from a clinical trial, showing a 94% objective response rate in patients with ROS1-positive non-small cell lung cancer. These results could support a regulatory approval application in the United States for first-line treatment, with significant implications for managing this aggressive disease.
Source: Gsk, published under the title "GSK presents positive registrational data to potentially exp..." - 14 September 2026
Read moreRis-Rez: 54% Reduction in Lung Cancer Mortality Risk
The results of the ARTEMIS-008 trial show that Ris-Rez offers a median survival of 18.5 months, surpassing topotecan, while presenting fewer severe side effects. GSK continues to develop this promising treatment for lung cancer and other solid tumors.
Source: Gsk, published under the title "Ris-Rez reduced risk of death by 54% versus topotecan in pat..." - 13 September 2026
Read moreUpdate on the SERENA-4 Phase III Trial of Etcamah with Palbociclib
This announcement contains privileged information regarding the Phase III clinical trial of Etcamah, a promising treatment for advanced ER-positive breast cancer, in combination with palbociclib, aimed at enhancing first-line therapeutic options for patients.
Source: Astrazeneca, published under the title "Update on SERENA-4 Phase III trial of Etcamah in combination..." - 12 September 2026
Read more
Food Systems Facing Climate and Economic Challenges
Climate pressures, changing consumer expectations, and rising costs are transforming food systems globally. The Kerry Health and Nutrition Institute shares insights on the need for industry collaboration and innovations to enhance the resilience and sustainability of food systems, while addressing evolving consumer needs and ensuring long-term food security.
Source: Kerry, published under the title "Feeding the Future: How Climate, Consumers and Costs are Res..." - 12 September 2026
Read more
The Importance of Defining Processed Foods for Public Health
The way we define processed foods can influence nutritional policies and consumer understanding. The Kerry Health & Nutrition Institute highlights the importance of a scientific approach to classifying foods, to support informed policy decisions and improve public health outcomes. This article explores the challenges of this definition and its implications for health and industry stakeholders.
Source: Kerry, published under the title "Beyond the Label: Why Processed Food Definitions Matter" - 12 September 2026
Read more
Kerry Appoints Lisa Turley as Chief Human Resources Officer
Kerry has announced the appointment of Lisa Turley as Chief Human Resources Officer, effective August 1. This decision aligns with the company's commitment to developing internal talent and fostering an inclusive and high-performing culture. With significant experience at Kerry, Lisa will lead the global human resources and culture agenda, thereby supporting the company's future growth ambitions.
Source: Kerry - 12 September 2026
Read moreJohnson & Johnson Unveils Advances on RYBREVANT at WCLC 2026
At the 2026 World Conference on Lung Cancer, Johnson & Johnson will showcase crucial data on RYBREVANT and RYBREVANT FASPRO, highlighting their impact on the survival of patients with non-small cell lung cancer (NSCLC) with EGFR mutations. The results will include analyses of overall survival and treatment-related events, reinforcing the clinical potential of these innovative therapies. RYBREVANT FASPRO, approved for subcutaneous use, represents a significant advancement in the treatment of adults with EGFR-mutated NSCLC, with prophylactic strategies to minimize adverse effects.
Source: J&j - 12 September 2026
Read more
SP Energy Networks Innovates with Fast Charging Solution for Electric Vehicles
SP Energy Networks, a subsidiary of Iberdrola in the UK, is deploying a fast charging technology for electric vehicles that combines energy storage and high-power charging. This initiative aims to facilitate the electrification of its fleet while reducing emissions and ensuring sustainable mobility.
Source: Iberdrola, published under the title "SP Energy Networks drives fleet electrification with an inno..." - 11 September 2026
Read more
Switzerland Enhances Patent Transparency in Plant Breeding
The revision of patent law in Switzerland imposes a disclosure requirement for patented characteristics of plant varieties, thereby providing greater certainty to breeders in the development of new varieties. This measure, adopted by the Federal Council, aims to stimulate innovation by clarifying intellectual property rights and facilitating access to the European market for Swiss breeders.
Source: Agropages, published under the title "Switzerland – Greater legal certainty in plant breeding" - 11 September 2026
Read more